Zheng, Bo
Wu, Mao-nian
Zhu, Shao-jun
Zhou, Hong-xia
Hao, Xiu-lan
Fei, Fang-qin
Jia, Yun
Wu, Jian
Yang, Wei-hua
Pan, Xue-ping
Funding for this research was provided by:
Zhejiang Medical and Health Research Project (2020PY027)
Huzhou Science and Technology Planning Program (2019GY13)
Natural Science Foundation of Zhejiang Province (LQ18F020002)
National Natural Science Foundation of China (61906066)
Article History
Received: 17 December 2020
Accepted: 17 September 2021
First Online: 9 October 2021
Declarations
:
: In China, the National Health and Family Planning Commission officially issued Measures for the Ethical Review of Biomedical Research Involving Humans in 2016. The Article 3 defines the biomedical research involving human subjects.Article 3. Biomedical research involving human subjects in the Measures includes:(1) activities of conducting research on human physiology, psychological behavior, pathological phenomena, causes and pathogenesis of diseases, as well as the prevention, diagnosis, treatment and rehabilitation of diseases, using modern methods in physics, chemistry, biology, traditional Chinese medicine and psychology, etc.;(2) activities of experimental research on the human body of new medical technologies or new medical products;(3) activities in which scientific research materials such as specimens, medical records and behaviors relating to humans are collected, recorded, used, reported or stored by epidemiological, sociological and psychological methods.This study mainly investigates people’s current understanding of the cross field application of artificial intelligence in medicine, which does not involve the activities stipulated in Article 3 of the censorship measures. Thus ethical review is not required for the study.Respondents were informed verbally as well as in written form in the questionnaire that completing and submitting the questionnaire meant they agreed to participate in the study.
: Not Applicable.
: The authors declared no competing interests.